Table 2.
Comparison of Prostate-Specific Antigen (PSA) Levels by Age in Patients With a Positive Prostate Biopsy, Group A vs Group B
| Age (years) | n | PSA <4 ng/mL | PSA 4–9.9 ng/mL | PSA 10 ng/mL and Higher |
|---|---|---|---|---|
| Group A | ||||
| <55 | 36 | 5 (13.9%) | 25 (69.4%) | 6 (16.6%) |
| 56–69 | 226 | 23 (10.2%) | 150 (66.4%) | 53 (23.5%) |
| 70-80 | 140 | 17 (12.1%) | 80 (57.1%) | 43 (30.7%) |
| Total | 402 | 45 (11.2%) | 255 (63.4%) | 102 (25.4%) |
| Group B | ||||
| <55 | 15 | 1 (6.7%) | 11 (73.3%) | 3 (20%) |
| 56-69 | 100 | 8 (8%) | 67 (67%) | 25 (25%) |
| 70–80 | 60 | 4 (7%) | 33 (55%) | 23 (38%) |
| Total | 175 | 13 (7.4%) | 111 (63.4%) | 51 (29.2%) |
PSA, Prostate-specific antigen.